Stay updated on BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:47:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    An NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:51:39.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page's footer revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T00:11:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed study content with an access-block screen. The page shows the standard 403 layout and navigation, indicating restricted access to the record.
    Difference
    19%
    Check dated 2026-09-23T00:58:15.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The revision number on the page was updated to v3.7.0, indicating a new build of the page. The update appears to reflect backend or front-end changes rather than new study data.
    Difference
    0.0%
    Check dated 2026-09-15T23:57:18.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.6) was introduced, replacing the previous v3.6.5, indicating an update to the page or its template rather than changes to study information.
    Difference
    0.0%
    Check dated 2026-09-01T19:44:52.000Z thumbnail image

Stay in the know with updates to BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BL-8040/Pembrolizumab Combo in Pancreatic Cancer Clinical Trial page.